The A1c (glycohemoglobin) test is a non-fasting, finger stick blood test designed to measure the percent (%) concentration of hemoglobin A1c (HbA1c) in individuals diagnosed with or suspected of having diabetes. The A1c test provides a reliable method to measure and/or assess the average level of individual diabetes control over the past 90 - 120 days.
This test is not substitute for daily (routine) blood glucose monitoring. Test results must be reported to and interpreted by a physician. High Performance Liquid Chromatography (HPLC) is the method used to analyze the blood sample. The reagent solution contains 1 ml of EDTA and (0.25 mmol) KCN (blood preservative).
Samples are stable for up to 30 days unrefrigerated. You should mail your sample as soon as possible or refrigerate until mailing. The HPLC analytical method detects and reports deteriorated or abnormal samples.
A1c provides an accurate and reliable method to routinely assess the relative level of diabetes control, level of mean blood glucose (MBG), effectiveness of treatment, and risk for development of possible acute and/or long-term chronic complications typically associated with sub-optimal diabetes control. Routine monitoring of A1c can improve patient compliance when used as part of a comprehensive treatment plan. A1c is an important test for individuals with all types of diabetes or those at risk for developing diabetes.






|
|
|
|
|
|
||
Registered with Washington Department of Veteran Affairs: www.dva.wa.gov |
|||||||